Get the Stockscreener App
198.67
0.09%
-0.2577
Natera Inc stock is traded at $198.67, with a volume of 1.16M.
It is down -0.09% in the last 24 hours and up +18.76% over the past month.
Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.
See More
Previous Close:
$198.93
Open:
$198.71
24h Volume:
1.16M
Relative Volume:
0.95
Market Cap:
$27.27B
Revenue:
$1.96B
Net Income/Loss:
$-253.24M
P/E Ratio:
-104.50
EPS:
-1.9012
Net Cash Flow:
$94.06M
1W Performance:
+3.40%
1M Performance:
+18.76%
6M Performance:
+26.87%
1Y Performance:
+60.08%
1-Day Range:
$194.07
$200.76
1-Week Range:
$188.06
$200.76
52-Week Range:
$121.01
$200.76
Natera Inc Stock (NTRA) Company Profile
Name
Natera Inc
Sector
Industry
Phone
650-249-9090
Address
13011 MCCALLEN PASS, AUSTIN, CA
Compare NTRA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NTRA
Natera Inc
|
198.70 | 27.30B | 1.96B | -253.24M | 94.06M | -1.9012 |
|
TMO
Thermo Fisher Scientific Inc
|
562.50 | 213.17B | 43.74B | 6.59B | 6.11B | 17.30 |
|
DHR
Danaher Corp
|
213.98 | 152.13B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
720.91 | 50.36B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
144.42 | 41.49B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
215.14 | 36.86B | 15.90B | 1.28B | 2.21B | 7.2842 |
Natera Inc Stock (NTRA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-27-25 | Upgrade | BNP Paribas Exane | Underperform → Neutral |
| Sep-22-25 | Resumed | Wells Fargo | Equal Weight |
| Mar-13-25 | Initiated | RBC Capital Mkts | Outperform |
| Jan-23-25 | Initiated | Barclays | Overweight |
| Jun-03-24 | Resumed | Jefferies | Buy |
| Apr-08-24 | Resumed | Craig Hallum | Buy |
| Feb-20-24 | Downgrade | Raymond James | Strong Buy → Outperform |
| Dec-29-23 | Reiterated | BTIG Research | Buy |
| Dec-14-23 | Initiated | Guggenheim | Buy |
| Dec-13-23 | Initiated | Wolfe Research | Outperform |
| Nov-13-23 | Upgrade | Raymond James | Outperform → Strong Buy |
| Sep-28-23 | Initiated | Bernstein | Mkt Perform |
| Jul-05-23 | Resumed | JP Morgan | Overweight |
| May-05-23 | Initiated | UBS | Buy |
| Jan-18-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Apr-25-22 | Initiated | Stephens | Overweight |
| Mar-08-22 | Initiated | Goldman | Buy |
| Jan-06-22 | Resumed | Piper Sandler | Overweight |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Jun-15-21 | Initiated | Raymond James | Mkt Perform |
| May-25-21 | Initiated | Wells Fargo | Overweight |
| Jan-28-21 | Initiated | Truist | Buy |
| Oct-08-20 | Initiated | BTIG Research | Buy |
| Sep-28-20 | Initiated | Morgan Stanley | Overweight |
| Sep-17-20 | Initiated | SVB Leerink | Outperform |
| Jun-10-20 | Resumed | Piper Sandler | Overweight |
| May-07-20 | Upgrade | JP Morgan | Neutral → Overweight |
| Oct-05-18 | Initiated | JP Morgan | Neutral |
| Jul-05-18 | Reiterated | Piper Jaffray | Overweight |
| Aug-07-17 | Reiterated | Morgan Stanley | Overweight |
| Nov-10-16 | Reiterated | The Benchmark Company | Buy |
| May-23-16 | Reiterated | The Benchmark Company | Buy |
| May-11-16 | Reiterated | The Benchmark Company | Buy |
| Apr-19-16 | Initiated | The Benchmark Company | Buy |
| Sep-28-15 | Upgrade | Wedbush | Neutral → Outperform |
| Aug-14-15 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Aug-04-15 | Initiated | Robert W. Baird | Outperform |
| Jul-27-15 | Initiated | Morgan Stanley | Equal-Weight |
| Jul-27-15 | Initiated | Piper Jaffray | Overweight |
| Jul-27-15 | Initiated | Wedbush | Neutral |
View All
Natera Inc Stock (NTRA) Latest News
Will Natera Inc. stock beat EPS estimatesJuly 2025 Breakouts & Safe Capital Growth Tips - newser.com
Carrier Screening Market Surges Amid Rising Demand for Genetic - openPR.com
Natera, Inc. $NTRA Shares Acquired by Zweig DiMenna Associates LLC - MarketBeat
Natera Shares Approach Critical Earnings Test - AD HOC NEWS
Is Natera Inc. stock a defensive play in 2025Earnings Beat & Intraday High Probability Alerts - newser.com
How Natera Inc. stock reacts to bond yields2025 Year in Review & Free High Accuracy Swing Entry Alerts - newser.com
Can momentum traders help lift Natera Inc.CPI Data & Long-Term Growth Plans - newser.com
Price momentum metrics for Natera Inc. explainedJuly 2025 Levels & Real-Time Chart Breakout Alerts - newser.com
Is Natera Inc. stock entering bullish territoryDay Trade & Daily Profit Maximizing Tips - newser.com
Why Natera Inc. stock could see breakout soon2025 Fundamental Recap & Community Driven Trade Alerts - newser.com
Y Intercept Hong Kong Ltd Makes New $1.69 Million Investment in Natera, Inc. $NTRA - MarketBeat
Ranking Natera Inc. among high performing stocks via toolsIndex Update & Weekly Top Stock Performers List - newser.com
Natera (NASDAQ:NTRA) Hits New 12-Month HighShould You Buy? - MarketBeat
Natera stock hits all-time high at 199.04 USD By Investing.com - Investing.com South Africa
Natera stock hits all-time high at 199.04 USD - Investing.com
Natera Expands Fetal Testing Tool to Include 20 Genes - MarketScreener
Natera Announces Expansion to 20 Genes for its Fetal Focus™ Single-Gene NIPT - Yahoo Finance
Regression analysis insights on Natera Inc. performance2025 Volume Leaders & Daily Price Action Insights - newser.com
Using portfolio simulators with Natera Inc. includedJuly 2025 WrapUp & Verified Chart Pattern Trade Signals - newser.com
Jennison Associates LLC Lowers Stock Holdings in Natera, Inc. $NTRA - MarketBeat
Natera, Inc. $NTRA Shares Acquired by Fjarde AP Fonden Fourth Swedish National Pension Fund - MarketBeat
How high can Natera Inc. stock goMarket Performance Report & Daily Stock Momentum Reports - newser.com
Natera (NASDAQ:NTRA) CFO Sells $150,201.92 in Stock - MarketBeat
Insider Selling: Natera (NASDAQ:NTRA) Insider Sells 781 Shares of Stock - MarketBeat
Insider Selling: Natera (NASDAQ:NTRA) CFO Sells 1,867 Shares of Stock - MarketBeat
Steven Leonard Chapman Sells 2,335 Shares of Natera (NASDAQ:NTRA) Stock - MarketBeat
Natera to Report its Third Quarter Results on November 6, 2025 - MarketScreener
Nisa Investment Advisors LLC Sells 7,378 Shares of Natera, Inc. $NTRA - MarketBeat
Is Natera Inc. stock positioned well for digital economyWeekly Risk Summary & Reliable Intraday Trade Alerts - newser.com
Key resistance and support levels for Natera Inc.Portfolio Update Summary & Free Weekly Watchlist of Top Performers - newser.com
Natera, Inc. Hits New 52-Week High of $198.99, Surging 72.41% - Markets Mojo
Natera, known for spotting cancer recurrence, wades into early detection - statnews.com
Natera reports progress in blood test for precancerous polyp detection By Investing.com - Investing.com Australia
Oppenheimer Asset Management Inc. Purchases 1,992 Shares of Natera, Inc. $NTRA - MarketBeat
Natera Inc Stock Analysis and ForecastMarket Breadth Indicators & Investment Risk Management Tips - earlytimes.in
Natera’s PROCEED-CRC Study: A Step Forward in Early Cancer Detection - The Globe and Mail
Natera (NTRA) Advances in Blood-Based CRC Screening with Promisi - GuruFocus
Natera Reports Strong Advanced Adenoma Data from Prospective PROCEED-CRC Trial, Demonstrating 22.5% Sensitivity and 91.5% Specificity - BioSpace
Natera Inc Stock (NTRA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.67%
1.24%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):